Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,457.00    6.00 (0.41%)
Bid:
1,464.00
Ask:
1,466.00
Spread: 2.00 (0.137%)
Market Cap: £3.08b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Block listing Interim Review

4 Oct 2021 09:55

RNS Number : 9028N
Hikma Pharmaceuticals Plc
04 October 2021
 

Hikma Pharmaceuticals PLC

 

 

Block Listing Six Monthly Return

 

Date: 4 October 2021

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")

 

Period of return

From: 1 April 2021

To:

30 September 2021

Balance of unallotted securities under scheme(s) from previous return:

SOP: 792,700 Ordinary Shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

SOP: 0 Ordinary Shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

SOP: 0 Ordinary Shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

SOP: 792,700 Ordinary Shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

 

Block Listing Six Monthly Return

 

Date: 4 October 2021

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")

Period of return

From: 1 April 2021

To:

30 September 2021

Balance of unallotted securities under scheme(s) from previous return:

LTIP: 57,502 Ordinary Shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

LTIP: 0 Ordinary Shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

LTIP: 0 Ordinary Shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

LTIP: 57,502 Ordinary Shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

Block Listing Six Monthly Return

 

Date: 4 October 2021

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("2009 MIP")

Period of return

From: 1 April 2021

To:

30 September 2021

Balance of unallotted securities under scheme(s) from previous return:

2009 MIP: 136,182 Ordinary Shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

2009 MIP: 0 Ordinary Shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

2009 MIP: 136,182 Ordinary Shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

2009 MIP: 0 Ordinary Shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

Block Listing Six Monthly Return

 

Date: 4 October 2021

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP")

Period of return

From: 1 April 2021

To:

30 September 2021

Balance of unallotted securities under scheme(s) from previous return:

2018 MIP: 1,000,000 Ordinary Shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

2018 MIP: 0 Ordinary Shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

2018 MIP: 226,506 Ordinary Shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

2018 MIP: 773,494 Ordinary Shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

Block Listing Six Monthly Return

 

Date: 4 October 2021

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")

Period of return

From: 1 April 2021

To:

30 September 2021

Balance of unallotted securities under scheme(s) from previous return:

EIP: 1,239,967 Ordinary Shares of 10 pence

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

EIP: 350,000 Ordinary Shares of 10 pence

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

EIP: 340,434 Ordinary Shares of 10 pence

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

EIP: 1,249,533 Ordinary Shares of 10 pence

 

Name of contact:

Peter Speirs

Telephone number of contact:

0207 399 2772

 

LEI: 549300BNS685UXH4JI75

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRUPGCAUUPGURC
Date   Source Headline
5th Jan 201111:32 amRNSTotal Voting Rights
16th Dec 20105:27 pmRNSDirector/PDMR Shareholding
6th Dec 20104:29 pmRNSDirector/PDMR Shareholding
1st Dec 20104:18 pmRNSDirector/PDMR Shareholding
12th Nov 20107:00 amRNSInterim Management Statement
9th Nov 20109:48 amRNSDirector/PDMR Shareholding
5th Nov 20103:37 pmRNSTotal Voting Rights
4th Nov 20104:15 pmRNSDirector/PDMR Shareholding
2nd Nov 201010:42 amRNSDirector/PDMR Shareholding
29th Oct 20107:00 amRNSAcquisition
18th Oct 20107:00 amRNSProduct Update
15th Oct 201011:10 amRNSBlock Listing for Share Schemes
4th Oct 20105:18 pmRNSTotal Voting Rights
4th Oct 20105:04 pmRNSBlocklisting Interim Review
1st Oct 20107:00 amRNSCompany Update
6th Sep 20103:53 pmRNSTotal Voting Rights
26th Aug 20107:00 amRNSInterim Results
4th Aug 20105:19 pmRNSVoting Rights and Capital
2nd Aug 201012:16 pmRNSAnnual Information Update
26th Jul 20105:30 pmRNSVoting Rights and Capital
13th May 20103:37 pmRNSAGM Statement
13th May 20107:00 amRNSInterim Management Statement
5th May 20105:48 pmRNSVoting Rights & Capital
23rd Apr 20103:16 pmRNSDirector/PDMR Shareholding
20th Apr 201010:02 amRNSDirector/PDMR Shareholding
12th Apr 20109:14 amRNSHikma expands in the Algerian market
9th Apr 20104:33 pmRNSAnnual Financial Report
9th Apr 201012:50 pmRNSDirector/PDMR Shareholding
9th Apr 201012:48 pmRNSDirector/PDMR Shareholding
8th Apr 201010:13 amRNSDirector/PDMR Shareholding
7th Apr 20107:00 amRNSHikma & CellTrion enter an exclusive partnership
7th Apr 20107:00 amRNSDirector/PDMR Shareholding
1st Apr 201012:23 pmRNSVoting Rights & Capital
1st Apr 201012:10 pmRNSBlocklisting Six Monthly return
30th Mar 20109:20 amRNSHikma expands in the Tunisian market
23rd Mar 20104:18 pmRNSDirector/PDMR Shareholding
17th Mar 20107:00 amRNSPreliminary Announcement for 2009
15th Mar 20109:43 amRNSBlocklisting of Shares
10th Mar 201011:00 amRNSTotal Voting Rights
1st Mar 20105:51 pmRNSNotice of Results
1st Feb 20101:40 pmRNSTotal Voting Rights
11th Jan 201012:00 pmRNSNon Regulatory Announcement
5th Jan 20102:10 pmRNSDirector/PDMR Shareholding
4th Jan 20106:28 pmRNSTotal Voting Rights
18th Dec 20093:17 pmRNSDirector/PDMR Shareholding
1st Dec 200910:05 amRNSTotal Voting Rights
1st Dec 200910:03 amRNSDirector/PDMR Shareholding
19th Nov 20093:07 pmRNSDirector/PDMR Shareholding
18th Nov 20094:37 pmRNSDirector/PDMR Shareholding
18th Nov 20094:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.